Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
Clin Immunol ; 226: 108713, 2021 05.
Artículo en Inglés | MEDLINE | ID: mdl-33711450

RESUMEN

Current chemical therapies for Chagas Disease (CD) lack ability to clear Trypanosoma cruzi (Tc) parasites and cause severe side effects, making search for new strategies extremely necessary. We evaluated the action of Tityus serrulatus venom (TsV) components during Tc infection. TsV treatment increased nitric oxide and pro-inflammatory cytokine production by Tc-infected macrophages (MØ), decreased intracellular parasite replication and trypomastigotes release, also triggering ERK1/2, JNK1/2 and p38 activation. Ts7 demonstrated the highest anti-Tc activity, inducing high levels of TNF and IL-6 in infected MØ. TsV/Ts7 presented synergistic effect on p38 activation when incubated with Tc antigen. KPP-treatment of MØ also decreased trypomastigotes releasing, partially due to p38 activation. TsV/Ts7-pre-incubation of Tc demonstrated a direct effect on parasite decreasing MØ-trypomastigotes releasing. In vivo KPP-treatment of Tc-infected mice resulted in decreased parasitemia. Summarizing, this study opens perspectives for new bioactive molecules as CD-therapeutic treatment, demonstrating the TsV/Ts7/KPP-trypanocidal and immunomodulatory activity during Tc infection.


Asunto(s)
Enfermedad de Chagas/tratamiento farmacológico , Inmunomodulación/efectos de los fármacos , Venenos de Escorpión/farmacología , Escorpiones/metabolismo , Animales , Enfermedad de Chagas/metabolismo , Femenino , Interleucina-6/metabolismo , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Activación de Macrófagos/efectos de los fármacos , Macrófagos/efectos de los fármacos , Ratones , Ratones Endogámicos C57BL , Óxido Nítrico/metabolismo , Factores de Necrosis Tumoral/metabolismo
2.
Mediators Inflamm ; 2019: 1872593, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31949423

RESUMEN

Multiple sclerosis (MS) is an inflammatory disease of the central nervous system (CNS). Experimental Autoimmune Encephalomyelitis (EAE) is the most widely used animal model for the study of MS. The Suppressor of Cytokine Signaling (SOCS) 2 protein plays a critical role in regulating the immune responses. The role of SOCS2 during EAE has not been explored. EAE was induced in WT and SOCS2-/- mice using myelin oligodendrocyte glycoprotein (MOG35-55) peptide. Brain and spinal cord were examined during the peak (day 14) and recovery phase (day 28) of the disease. SOCS2 was upregulated in the brain of WT mice at the peak and recovery phase of EAE. The development of the acute phase was slower in onset in SOCS2-/- mice and was associated with reduced number of Th1 (CD3+CD4+IFN-γ +) cells in the spinal cord and brain. However, while in WT mice, maximal clinical EAE score was followed by a progressive recovery; the SOCS2-/- mice were unable to recover from locomotor impairment that occurred during the acute phase. There was a prolonged inflammatory response (increased Th1 and decreased Th2 and T regulatory cells) in the late phase of EAE in the CNS of SOCS2-/- mice. Transplantation of bone marrow cells from SOCS2-/- into irradiated WT mice resulted in higher lethality at the early phase of EAE. Altogether, these results suggest that SOCS2 plays a dual role in the immune response during EAE. It is necessary for damage during the acute phase damage but plays a beneficial role in the recovery stage of the disease.


Asunto(s)
Encefalomielitis Autoinmune Experimental/inmunología , Encefalomielitis Autoinmune Experimental/metabolismo , Proteínas Supresoras de la Señalización de Citocinas/metabolismo , Animales , Western Blotting , Sistema Nervioso Central/inmunología , Sistema Nervioso Central/metabolismo , Encefalomielitis Autoinmune Experimental/genética , Femenino , Citometría de Flujo , Inflamación/inmunología , Inflamación/metabolismo , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Proteínas Supresoras de la Señalización de Citocinas/genética , Células TH1/metabolismo , Células Th17/metabolismo , Células Th2/metabolismo
3.
Artículo en Inglés | MEDLINE | ID: mdl-27993857

RESUMEN

Current treatments for chronic Chagas cardiomyopathy, a disease with high mortality rates and caused by the protozoan Trypanosoma cruzi, are unsatisfactory. Myocardial inflammation, including endothelial activation, is responsible for the structural and functional damage seen in the chronic phase. The clinical efficacy of benznidazole could be improved by decreasing chronic inflammation. Statins, which have anti-inflammatory properties, may improve the action of benznidazole. Here, the action of simvastatin in a murine model of chronic Chagas cardiomyopathy and the link with the production of the proresolving eicosanoid 15-epi-lipoxin A4, produced by 5-lipoxygenase, are evaluated. Simvastatin decreased the expression of the adhesion molecules E-selectin, intracellular adhesion molecule type 1 (ICAM-1), and vascular cell adhesion molecule type 1 (VCAM-1) in T. cruzi-infected mice. However, when this drug was administered to 5-lipoxygenase-deficient mice, the anti-inflammatory effect was not observed unless exogenous 15-epi-lipoxin A4 was administered. Thus, in chronic Chagas disease, 5-epi-lipoxin A4 induced by simvastatin treatment could improve the pathophysiological condition of patients by increasing the trypanocidal action of benznidazole.


Asunto(s)
Anticolesterolemiantes/farmacología , Cardiomiopatía Chagásica/tratamiento farmacológico , Nitroimidazoles/farmacología , Parasitemia/tratamiento farmacológico , Simvastatina/farmacología , Tripanocidas/farmacología , Animales , Araquidonato 5-Lipooxigenasa/deficiencia , Araquidonato 5-Lipooxigenasa/genética , Cardiomiopatía Chagásica/metabolismo , Cardiomiopatía Chagásica/mortalidad , Cardiomiopatía Chagásica/parasitología , Enfermedad Crónica , Modelos Animales de Enfermedad , Quimioterapia Combinada , Selectina E/genética , Selectina E/metabolismo , Endotelio/efectos de los fármacos , Endotelio/metabolismo , Endotelio/parasitología , Regulación de la Expresión Génica , Humanos , Molécula 1 de Adhesión Intercelular/genética , Molécula 1 de Adhesión Intercelular/metabolismo , Lipoxinas/antagonistas & inhibidores , Lipoxinas/metabolismo , Lipoxinas/farmacología , Masculino , Ratones , Ratones Endogámicos BALB C , Ratones Noqueados , Miocardio/metabolismo , Miocardio/patología , Parasitemia/metabolismo , Parasitemia/mortalidad , Parasitemia/parasitología , Análisis de Supervivencia , Trypanosoma cruzi/efectos de los fármacos , Trypanosoma cruzi/crecimiento & desarrollo , Trypanosoma cruzi/patogenicidad , Molécula 1 de Adhesión Celular Vascular/genética , Molécula 1 de Adhesión Celular Vascular/metabolismo
4.
Curr Opin Infect Dis ; 28(3): 246-52, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-25887609

RESUMEN

PURPOSE OF REVIEW: American trypanosomiasis, or Chagas disease, is a lifelong and persistent infection caused by the protozoan Trypanosoma cruzi and is the most significant cause of morbidity and mortality in South and Central America. Owing to immigration and additional risks from blood transfusion and organ transplantation, the number of reported cases of Chagas disease has increased recently in Europe and the USA. The disease is caused by a moderate to intense lasting inflammatory response that triggers local expression of inflammatory mediators and activates and recruits leukocytes to various tissues to eliminate the parasites. RECENT FINDINGS: This long-term inflammatory process triggers biochemical, physiological and morphological alterations and clinical changes in the digestive, nervous and cardiac (e.g. myocarditis, arrhythmias, congestive heart failure, autonomic dysfunctions and microcirculatory disturbances) systems. Indeed, the pathogenesis of Chagas disease is intricate and multifactorial, and the roles of the parasite and the immune response in initiating and maintaining the disease are still controversial. SUMMARY: In this review, we discuss the current knowledge of 'strategies' employed by the parasite to persist in the host and host defence mechanisms against Trypanosoma cruzi infection, which can result in equilibrium (absence of the disease) or disease development, mainly in the cardiac systems.


Asunto(s)
Enfermedad de Chagas/fisiopatología , Inflamación/parasitología , Miocardio/patología , Tripanocidas/uso terapéutico , Trypanosoma cruzi/genética , Anticuerpos Antiprotozoarios/sangre , Autoinmunidad , Enfermedad de Chagas/inmunología , Enfermedad de Chagas/parasitología , Enfermedad de Chagas/patología , Corazón/parasitología , Interacciones Huésped-Parásitos , Humanos , Trypanosoma cruzi/aislamiento & purificación
5.
Tissue Cell ; 80: 101991, 2023 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-36462383

RESUMEN

Mormoopidae is an exclusive Neotropical family of bats, distributed from southern Mexico to northeastern Brazil. Possibly due to its endemic distribution and very low occurrence (rarity), descriptions of their reproductive accessory glands (RAGs) are still lacking. Thus, this study aims to characterize the male RAGs of Pteronotus gymnonotus (Mormoopidae: Chiroptera). Results demonstrate that the RAGs of P. gymnonotus is composed of a prostatic complex, comprising two regions (ventral and dorsal prostates); urethral (Littre) glands, a pair of bulbourethral and ampullary glands, with the absence of seminal vesicles. The ventral prostate has an atypical epithelium, due to its holocrine secretion; which contains numerous PAS-positive globular vesicles. The dorsal prostate has a cubic-to-columnar pseudostratified epithelium, containing fluid PAS-negative secretion. The ampullary glands present cubic-to-columnar pseudostratified epithelium, with secretion varying from granular and PAS-negative to fluid and PAS-positive. Urethral glands are dispersed in the submucosa of the urethra, while the bulbourethral glands are located in the penile root. Both glands have cubic-to-columnar pseudostratified epithelium with PAS-positive globular secretion. In conclusion, we propose that the RAGs of P. gymnonotus possibly evolved from a common emballonurid ancestor, shared with the families Phyllostomidae and Noctilionidae, but with the development of an exclusive apomorphy, the ampullary glands.


Asunto(s)
Quirópteros , Animales , Masculino , Próstata , Glándulas Bulbouretrales , Uretra , Reproducción/fisiología
6.
Anat Rec (Hoboken) ; 306(8): 2135-2152, 2023 08.
Artículo en Inglés | MEDLINE | ID: mdl-36579698

RESUMEN

Despite the high number of species and wide geographic dispersion, reproductive accessory glands (RAGs) of bats have traditionally received little attention in the literature, with some species not even having a basic description of their composition and structure. Thus, this study aimed to analyze and compare the composition, anatomy, and histology of male RAGs of bat species belonging to three of the largest (cosmopolitan) bat families: Vespertilionidae (Histiotus velatus), Molossidae (Molossus rufus), and Emballonuridae (Peropteryx leucoptera), in order to understand the variations in the bat RAGs. The results showed that the RAGs of H. velatus, M. rufus, and P. leucoptera are composed of an intra-abdominal prostatic complex, associated with the urethra, urethral glands, and a pair of inguinal bulbourethral glands; without ampullary glands or seminal vesicles. The prostatic complex can be composed of two (M. rufus and P. leucoptera) or three (H. velatus) prostatic regions, and can be compact (P. leucoptera), semi-lobed (M. rufus), or multilobed (H. velatus). Each prostatic region has unique and distinct characteristics, with the ventral region presenting a holocrine nature, exclusive to bats; while the dorsal and/or dorsolateral regions have similar characteristics to the ventral prostate of rats and to the human peripheral zone.


Asunto(s)
Quirópteros , Humanos , Masculino , Animales , Ratas , Quirópteros/anatomía & histología , Próstata/anatomía & histología , Glándulas Bulbouretrales/anatomía & histología , Uretra , Reproducción
8.
Front Cell Infect Microbiol ; 11: 706618, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34354963

RESUMEN

Toxoplasmosis, caused by Toxoplasma gondii, is a major public concern owing to its neurotropic nature and high morbidity and mortality rates in immunocompromised patients and newborns. Current treatment for this disease is inefficient and produces side effects. Inflammatory mediators produced during T. gondii infection (e.g., cytokines and nitric oxide) are crucial in controlling parasite replication. In this context, Tityus serrulatus venom (TsV) induces the production of inflammatory mediators by immune cells. Thus, this study aimed to isolate and identify the components of TsV with potential anti-T. gondii activity. TsV was extracted from scorpions and lyophilized or loaded onto a column to obtain its fractions. TsV subfractions were obtained using chromatography, and its amino acid sequence was identified and applied to peptide design using bioinformatics tools. The C57BL/6 mice and their harvested macrophages were used to test the anti-Toxoplasma activity of TsV components and peptides. TsV and its fraction F6 attenuated the replication of tachyzoites in macrophages and induced nitric oxide and cytokine (IL-12, TNF, and IL-6) production by infected cells, without host cell toxicity. Moreover, Su6-B toxin, a subfraction of F6, demonstrated anti-T. gondii activity. The partially elucidated and characterized amino acid sequence of Sub6-B demonstrated 93% similarity with T. serrulatus 2 toxin (Ts2). Ts2 mimetic peptides ("Pep1," "Pep2a," and "Pep2b") were designed and synthesized. Pep1 and Pep2a, but not Pep2b, reduced the replication of tachyzoites in macrophages. In vivo, treatment of T. gondii-infected mice with Pep1, Pep2a, or Pep2b decreased the number of cerebral cysts and did not induce hepatotoxicity in the animals. Taken together, our data show promising immunomodulatory and antiparasitic activity of TsV that could be explored and applied in future therapies for treating infectious parasitic diseases such as toxoplasmosis.


Asunto(s)
Venenos de Escorpión , Toxoplasmosis , Animales , Técnicas de Química Sintética , Citocinas , Humanos , Ratones , Ratones Endogámicos C57BL , Venenos de Escorpión/uso terapéutico , Escorpiones , Toxoplasma , Toxoplasmosis/tratamiento farmacológico
9.
Estud. psicol. (Natal) ; 27(2): 137-145, mai-ago 2022.
Artículo en Portugués | LILACS | ID: biblio-1426162

RESUMEN

O objetivo deste estudo foi analisar a presença de transtornos mentais comuns e sintomas de ansiedade e depressão em idosos brasileiros durante a pandemia da COVID-19. Participaram 237 idosos, com idades variando entre 60 e 88 anos, sendo 78,5% do sexo feminino, com 97,9% afirmando estar em quarentena. Os instrumentos utilizados foram questionário sociodemográfico, o Self-Reporting Questionnaire (SRQ-20) e a Escala Hospitalar de Ansiedade e Depressão (HAD). Os transtornos mentais comuns foram mais frequentes em mulheres, idosos com renda mensal inferior a dois salários-mínimos e entre aqueles com maior percepção de vulnerabilidade à COVID-19. Pessoas com maior percepção de risco à COVID-19 também apresentaram maior ocorrência de distress e sintomas de ansiedade e depressão. Faz-se necessário o cuidado em saúde mental, sobretudo das mulheres idosas, das pessoas idosas com menor acesso à renda e daquelas que se percebem mais vulneráveis ao vírus.


The aim of this study was to analyze the presence of common mental disorders and symptoms of anxiety and depression in Brazilian elderly during the COVID-19 pandemic. Two hundred thirty-seven elderly people, with ages varying between 60 and 88 years old, participated, being 78.5% female and 97.9% claiming to be in quarantine. The instruments used were a sociodemographic questionnaire, the Self-Reporting Questionnaire (SRQ-20) and the Hospital Anxiety and Depression Scale (HAD). Common mental disorders were more frequent in women, elderly people with monthly income below two minimum wages and among those with a greater perception of vulnerability to COVID-19. People with a higher perceived risk of COVID-19 also had a higher occurrence of distress and symptoms of anxiety and depression. In this sense, mental health care is necessary, especially for elderly women, elderly people with less access to income and those who perceive themselves as more vulnerable to the virus.


El objetivo de este estudio fue analizar la presencia de trastornos mentales comunes, síntomas de ansiedad y depresión en ancianos brasileños durante la pandemia del COVID-19. Participaron doscientas treinta y siete personas mayores, con edades que varían entre 60 y 88 años, siendo 78.5% mujeres y 97.9% afirmando estar en cuarentena. Los instrumentos utilizados fueron el cuestionario sociodemográfico, el Self-Reporting Questionnaire (SRQ-20) y la Escala de Ansiedad y Depresión Hospitalaria (HAD). Los trastornos mentales comunes fueron más frecuentes en mujeres, personas mayores con ingresos mensuales por debajo de dos salarios mínimos y entre aquellos con una mayor percepción de vulnerabilidad al COVID-19. Las personas con un mayor riesgo percibido ante el COVID-19 también tenían una mayor incidencia de distrés psicológico y síntomas de ansiedad y depresión. En este sentido, la atención a la salud mental es necesaria, especialmente para las mujeres de edad avanzada, las personas de edad avanzada con menos acceso a los ingresos y aquellas que se perciben a sí mismas como más vulnerables al virus.


Asunto(s)
Humanos , Femenino , Anciano , Anciano de 80 o más Años , Anciano , Distrés Psicológico , COVID-19 , Trastornos Mentales , Ansiedad , Depresión
10.
Mol Neurobiol ; 54(9): 7063-7082, 2017 11.
Artículo en Inglés | MEDLINE | ID: mdl-27796746

RESUMEN

Cerebral malaria (CM) is a life-threatening complication of Plasmodium falciparum infection, which can result in long-term cognitive and behavioral deficits despite successful anti-malarial therapy. Due to the substantial social and economic burden of CM, the development of adjuvant therapies is a scientific goal of highest priority. Apart from vascular and immune responses, changes in glutamate system have been reported in CM pathogenesis suggesting a potential therapeutic target. Based on that, we hypothesized that interventions in the glutamatergic system induced by blockage of N-methyl-D-aspartate (NMDA) receptors could attenuate experimental CM long-term cognitive and behavioral outcomes. Before the development of evident CM signs, susceptible mice infected with Plasmodium berghei ANKA (PbA) strain were initiated on treatment with dizocilpine maleate (MK801, 0.5 mg/kg), a noncompetitive NMDA receptor antagonist. On day 5 post-infection, mice were treated orally with a 10-day course chloroquine (CQ, 30 mg/kg). Control mice also received saline, CQ or MK801 + CQ therapy. After 10 days of cessation of CQ treatment, magnetic resonance images (MRI), behavioral and immunological assays were performed. Indeed, MK801 combined with CQ prevented long-term memory impairment and depressive-like behavior following successful PbA infection resolution. In addition, MK801 also modulated the immune system by promoting a balance of TH1/TH2 response and upregulating neurotrophic factors levels in the frontal cortex and hippocampus. Moreover, hippocampus abnormalities observed by MRI were partially prevented by MK801 treatment. Our results indicate that NMDA receptor antagonists can be neuroprotective in CM and could be a valuable adjuvant strategy for the management of the long-term impairment observed in CM.


Asunto(s)
Conducta Animal , Cognición , Maleato de Dizocilpina/uso terapéutico , Antagonistas de Aminoácidos Excitadores/uso terapéutico , Malaria Cerebral/tratamiento farmacológico , Malaria Cerebral/fisiopatología , Fármacos Neuroprotectores/uso terapéutico , Receptores de Glutamato/metabolismo , Animales , Ansiedad/complicaciones , Ansiedad/tratamiento farmacológico , Ansiedad/fisiopatología , Conducta Animal/efectos de los fármacos , Cognición/efectos de los fármacos , Citocinas/sangre , Citocinas/metabolismo , Depresión/complicaciones , Depresión/tratamiento farmacológico , Depresión/fisiopatología , Maleato de Dizocilpina/farmacología , Antagonistas de Aminoácidos Excitadores/farmacología , Femenino , Ácido Glutámico/metabolismo , Hipocampo/metabolismo , Hipocampo/patología , Leucocitos/metabolismo , Imagen por Resonancia Magnética , Malaria Cerebral/complicaciones , Malaria Cerebral/patología , Memoria a Corto Plazo/efectos de los fármacos , Ratones Endogámicos C57BL , Factores de Crecimiento Nervioso/metabolismo , Fármacos Neuroprotectores/farmacología , Tamaño de los Órganos , Parasitemia/sangre , Parasitemia/complicaciones , Parasitemia/patología , Fenotipo , Plasmodium berghei/efectos de los fármacos , Receptores de N-Metil-D-Aspartato/antagonistas & inhibidores , Receptores de N-Metil-D-Aspartato/metabolismo , Análisis de Supervivencia , Regulación hacia Arriba
11.
Vet Parasitol ; 186(3-4): 207-15, 2012 May 25.
Artículo en Inglés | MEDLINE | ID: mdl-22177333

RESUMEN

Toxoplasmosis is a world wide spread zoonosis caused by Toxoplasma gondii, an obligate intracellular parasite that is able to disseminate into deep tissues and cross biological barriers, reaching immunoprivileged sites such as the brain and retina. The parasite is able to infect macrophages and dendritic cells for dispersal throughout the body. However, the molecular mechanisms or outcomes of the subversion of the host cell are largely unknown. Recently our group established that metalloproteinases are involved in migration of infected macrophages. Herein, we evaluated the recruitment of host invasive machinery components in T. gondii infected murine macrophages. We showed by immunoprecipitation assays that MMP-9, CD44 TIMP-1 and uPAR were secreted as a multi-protein complex by infected macrophages. Zymographic analysis revealed that MMP-9 was present in its pro- and active form. Moreover, inhibition of uPA/uPAR pathway by PAI-1 decreased secretion of MMP-9 active forms, as well those associated to uPAR and TIMP-1, but not to CD44. Data presented here suggest that MMP-9 is secreted as a multiprotein complex by T. gondii infected macrophages, similar to that observed in metastatic cells. We further speculate that uPA/uPAR system is involved in the expression/secretion of complexes containing active MMP-9 forms.


Asunto(s)
Macrófagos/metabolismo , Macrófagos/parasitología , Receptores del Activador de Plasminógeno Tipo Uroquinasa/metabolismo , Toxoplasma/fisiología , Activador de Plasminógeno de Tipo Uroquinasa/metabolismo , Animales , Línea Celular , Regulación de la Expresión Génica , Receptores de Hialuranos/genética , Receptores de Hialuranos/metabolismo , Metaloproteinasa 9 de la Matriz/genética , Metaloproteinasa 9 de la Matriz/metabolismo , Ratones , Inhibidor 1 de Activador Plasminogénico/genética , Inhibidor 1 de Activador Plasminogénico/metabolismo , Receptores del Activador de Plasminógeno Tipo Uroquinasa/genética , Activador de Plasminógeno de Tipo Uroquinasa/genética
12.
Vet Parasitol ; 169(3-4): 312-9, 2010 May 11.
Artículo en Inglés | MEDLINE | ID: mdl-20080350

RESUMEN

Toxoplasmosis is a world wide spread zoonosis caused by Toxoplasma gondii, an obligate intracellular parasite that is able to disseminate into deep tissues and cross biological barriers, reaching immunoprivileged sites such as the brain and retina. The parasite is able to infect macrophages and dendritic cells for dispersal throughout the body. However, the molecular principals or outcomes of the subversion of the host cell are largely unknown. We evaluated the involvement of host invasive machinery in the migration of T. gondii infected murine cells from a monocytic/macrophage lineage. Migration in Matrigel of infected macrophages was augmented after 48 h of infection, and inhibition of metalloproteinases abolished migration. We also demonstrated that T. gondii infection induces a decreasing of CD44 at cell surface independent of the ERK signaling pathway, and that secretion of active MMP9 is augmented upon infection. Infected macrophages showed increased expression of MT1-MMP and ADAM10 membrane matrix metalloproteinases. Furthermore, processing of pro-alpha v and pro-beta 3 in T. gondii infected cells seems to depend on metalloproteinases to generate functional mature integrin alpha v beta 3 molecules, with no evidence of the involvement of proprotein convertase pathway.


Asunto(s)
Receptores de Hialuranos/metabolismo , Integrina alfaVbeta3/metabolismo , Macrófagos/parasitología , Metaloproteinasas de la Matriz/metabolismo , Toxoplasma/patogenicidad , Proteínas ADAM/metabolismo , Proteína ADAM10 , Secretasas de la Proteína Precursora del Amiloide/metabolismo , Animales , Macrófagos/inmunología , Macrófagos/metabolismo , Metaloproteinasa 14 de la Matriz/metabolismo , Proteínas de la Membrana/metabolismo , Ratones
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA